Single dose of New Limit's cellular reprogramming therapy improves survival in alcohol liver damage mouse models over multiple months of repeated alcohol cycles

Treated old mice do not exhibit the hangover behavior that untreated old mice display. The therapy both prevents new damage and helps the liver regenerate existing damage. "In young animals, when you expose them to a damaging diet like alcohol, they're generally fine. They behave normally like young mice do. They run around. They look for their next adventure. Party on, man. In old mice, they actually become terribly sedated. They flip on their backs. They sleep for about 8 to 12 hours at a time." The mechanism is not about metabolizing alcohol faster — it is about restoring the hepatocyte's youthful resilience and regenerative capacity. The therapy uses mRNA encoding the transcription factors, delivered via lipid nanoparticles (LNPs) — the same delivery technology used by Moderna and BioNTech for COVID-19 vaccines, and by gene-editing companies targeting the liver. Human trials next year in Australia. [https://youtu.be/xA3-1iXv5Hk?si=QXPPY5RjaB5vA1ob](https://youtu.be/xA3-1iXv5Hk?si=QXPPY5RjaB5vA1ob) [https://finance.biggo.com/podcast/5af62902f5f6c02c](https://finance.biggo.com/podcast/5af62902f5f6c02c)